Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224256101> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4224256101 endingPage "e29134" @default.
- W4224256101 startingPage "e29134" @default.
- W4224256101 abstract "Abstract Rationale: Anaplastic lymphoma kinase (ALK) fusion, an important oncogenic mutation, occurs in 3% to 7% of non-small cell lung cancer (NSCLC) cases, and EML4 is the most common partner gene. With the widespread application of next-generation sequencing (NGS), more gene breakpoint fusions have been discovered and functional fusion transcripts can provide targeted clinical benefits. Patient concerns and diagnosis: A 40-year-old woman was diagnosed with lung adenocarcinoma with brain metastases. A novel CLHC1/RNT4 intergenic region, ALK (Exon20-29) (abundance 39.97%), was identified using lung puncture tissue by NGS analysis (Simceredx), and results of immunohistochemistry and fluorescence in situ hybridization confirmed ALK fusion. Interventions and outcomes: The patient was administered oral crizotinib (250 mg bid) combined with endostar (30 mg d1-7) for 12 cycles from June 18, 2020. The patient's condition was controlled, and the curative effect was evaluated as stable disease (SD). Unfortunately, brain magnetic resonance images showed multiple nodules in the left cerebellar hemisphere, and chest computed tomography showed no significant changes in the progression of the disease. Subsequently, alectinib (600 mg bid) was administered on April 1, 2021. Brain lesions were significantly reduced and partial remission (PR) was achieved. No significant changes were observed in the lung lesions. Lessons: ALK fusion is a risk factor for brain metastasis (BM) in patients with advanced non-small NSCLC patients. In our case, a novel CLHC1/RNT4 intergenic region, ALK fusion, was identified for the first time in a lung adenocarcinoma patient with BM, who benefited from crizotinib and endostar sequential alectinib. Our case highlights the advantages of NGS for fusion detection and provides promising treatment options for NSCLC patients with BM harboring ALK fusions." @default.
- W4224256101 created "2022-04-26" @default.
- W4224256101 creator A5012716319 @default.
- W4224256101 creator A5019324414 @default.
- W4224256101 creator A5037843732 @default.
- W4224256101 creator A5051735034 @default.
- W4224256101 creator A5059590638 @default.
- W4224256101 creator A5091516793 @default.
- W4224256101 date "2022-04-08" @default.
- W4224256101 modified "2023-10-14" @default.
- W4224256101 title "Effective treatment in lung adenocarcinoma patient with brain metastases harboring novel CLHC1/RNT4 intergenic region- ALK fusion" @default.
- W4224256101 cites W2050368996 @default.
- W4224256101 cites W2885651891 @default.
- W4224256101 cites W2969638499 @default.
- W4224256101 cites W2988542587 @default.
- W4224256101 cites W2990246067 @default.
- W4224256101 cites W3009104858 @default.
- W4224256101 cites W3013156476 @default.
- W4224256101 cites W3023638286 @default.
- W4224256101 cites W3032247589 @default.
- W4224256101 cites W3035918595 @default.
- W4224256101 doi "https://doi.org/10.1097/md.0000000000029134" @default.
- W4224256101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35446297" @default.
- W4224256101 hasPublicationYear "2022" @default.
- W4224256101 type Work @default.
- W4224256101 citedByCount "0" @default.
- W4224256101 crossrefType "journal-article" @default.
- W4224256101 hasAuthorship W4224256101A5012716319 @default.
- W4224256101 hasAuthorship W4224256101A5019324414 @default.
- W4224256101 hasAuthorship W4224256101A5037843732 @default.
- W4224256101 hasAuthorship W4224256101A5051735034 @default.
- W4224256101 hasAuthorship W4224256101A5059590638 @default.
- W4224256101 hasAuthorship W4224256101A5091516793 @default.
- W4224256101 hasBestOaLocation W42242561011 @default.
- W4224256101 hasConcept C117643217 @default.
- W4224256101 hasConcept C121608353 @default.
- W4224256101 hasConcept C126322002 @default.
- W4224256101 hasConcept C142724271 @default.
- W4224256101 hasConcept C143998085 @default.
- W4224256101 hasConcept C2776232967 @default.
- W4224256101 hasConcept C2776256026 @default.
- W4224256101 hasConcept C2777714996 @default.
- W4224256101 hasConcept C2778164965 @default.
- W4224256101 hasConcept C2779013556 @default.
- W4224256101 hasConcept C2779220645 @default.
- W4224256101 hasConcept C2779422266 @default.
- W4224256101 hasConcept C2781182431 @default.
- W4224256101 hasConcept C71924100 @default.
- W4224256101 hasConceptScore W4224256101C117643217 @default.
- W4224256101 hasConceptScore W4224256101C121608353 @default.
- W4224256101 hasConceptScore W4224256101C126322002 @default.
- W4224256101 hasConceptScore W4224256101C142724271 @default.
- W4224256101 hasConceptScore W4224256101C143998085 @default.
- W4224256101 hasConceptScore W4224256101C2776232967 @default.
- W4224256101 hasConceptScore W4224256101C2776256026 @default.
- W4224256101 hasConceptScore W4224256101C2777714996 @default.
- W4224256101 hasConceptScore W4224256101C2778164965 @default.
- W4224256101 hasConceptScore W4224256101C2779013556 @default.
- W4224256101 hasConceptScore W4224256101C2779220645 @default.
- W4224256101 hasConceptScore W4224256101C2779422266 @default.
- W4224256101 hasConceptScore W4224256101C2781182431 @default.
- W4224256101 hasConceptScore W4224256101C71924100 @default.
- W4224256101 hasIssue "14" @default.
- W4224256101 hasLocation W42242561011 @default.
- W4224256101 hasLocation W42242561012 @default.
- W4224256101 hasLocation W42242561013 @default.
- W4224256101 hasLocation W42242561014 @default.
- W4224256101 hasOpenAccess W4224256101 @default.
- W4224256101 hasPrimaryLocation W42242561011 @default.
- W4224256101 hasRelatedWork W2400744927 @default.
- W4224256101 hasRelatedWork W2503069423 @default.
- W4224256101 hasRelatedWork W2516942920 @default.
- W4224256101 hasRelatedWork W2624310346 @default.
- W4224256101 hasRelatedWork W2941535758 @default.
- W4224256101 hasRelatedWork W3174215211 @default.
- W4224256101 hasRelatedWork W3197633853 @default.
- W4224256101 hasRelatedWork W3199005851 @default.
- W4224256101 hasRelatedWork W4308551119 @default.
- W4224256101 hasRelatedWork W4380730022 @default.
- W4224256101 hasVolume "101" @default.
- W4224256101 isParatext "false" @default.
- W4224256101 isRetracted "false" @default.
- W4224256101 workType "article" @default.